RE: Trading volume4 Mar 2021 16:32
Its priced for failure, they are going to report another loss of circa £1.7m, they **had** about £1.5m (from memory) in the bank and have a large 4.5m debt that may need repaying in September.
There are simply better Covid recovery plays out there, so this company goes largely unnoticed, especially given the risks listed above.
That said, I keep the faith that this is the bottom. I see a company that spends a lot in R&D and I hope it pays dividends for them. Furthermore, they could also cut their circa £4.5m R&D spend and start building cash if they were desperate. They also pay their BoD too much for what they have delivered for us - so a few heads could roll and ease some cash flow. To be fair, the company has cut costs a lot so any upside for them should be magnified.
To answer your question:
A few director deals may perk things up a bit and obviously, solid contract announcements.
PS. Not my worst company - seen many go down, when will I ever learn.